Search clinical trials for: TIMP-GLIA

Total 2349 results

Takeda
COUR Pharmaceutical Development Company, Inc.

Completed

Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease

Celiac Disease

United States
Takeda

Active, not recruiting

Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet

Celiac Disease

United States, Canada
Takeda
COUR Pharmaceuticals Development Company, Inc.

Completed

Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease

Celiac Disease

United States
University of Pavia

Not yet recruiting

Non-surgical Periodontal Treatment With Adjunctive Use of Lactoferrin Contained in Toothpaste and Mouthwash

Periodontal Diseases

Italy
IDRI
Rockefeller University

Completed

The Effects of GLA (5 mcg) on Human Volunteers

Healthy Volunteers

United States
University of Virginia

Active, not recruiting

GIA in Cascade Testing (GIA)

Genetic Predisposition

United States
University Hospital, Clermont-Ferrand

Completed

Histopathologic Evaluation of High Grade Brain Tumors by High Order Diffusion Tensor Imaging (TeDi-C2)

High Grade Brain Tumor

France
University Medical Center Groningen
GGZ Drenthe Mental Health Institution

Recruiting

Lifestyle InterVEntion Study in General Practice: LIVES - GP (LIVES-GP)

Cardiovascular Diseases | Depression, Unipolar

Netherlands
Rockefeller University
Immune Design; IDRI Corporation

Completed

The Effects of GLA on Human Volunteers

Healthy Volunteers

United States
Medtronic - MITG

Terminated

ENDO GIA Stapler With Duet Tissue Reinforcement System (TRS) Used in Pulmonary Resections

Lung Disease

Japan
Chiayi Christian Hospital
Sanofi

Unknown

Epidemiological Study of Fabry Disease in Taiwan Young Stroke Patients

Fabry Disease
Q Therapeutics, Inc.

Recruiting

Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis

Transverse Myelitis

United States
Q Therapeutics, Inc.

Not yet recruiting

Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis
Jørgen Bjerggaard Jensen

Completed

Endo-GIA Versus Endowrist Stapler in Intracorporeal Urinary Diversion in Robotic Assisted Radical Cystectomy (EGIAES)

Bladder Cancer

Denmark
Gaia AG
University of Giessen; Universitätsklinikum Hamburg-Eppendorf

Recruiting

Effectiveness of a Digital Health Application for Psoriasis

Psoriasis

Germany
Sanwa BioTech Limited
Chinese University of Hong Kong; Prince of Wales Hospital, Shatin, Hong Kong

Not yet recruiting

Influenza A+B Test Kit Performance Study

Influenza Type B | Influenza Type A

Hong Kong
Fundació Sant Joan de Déu
University of Seville; University of Barcelona

Active, not recruiting

Intervention to Prevent Mental Health Disorders of Women and Their Partners Who Experienced Pregnancy Loss (Enzo)

Stillbirth and Fetal Death

Spain
North Bristol NHS Trust

Completed

GDNF in ideopathicParkinsons Disease

Idiopathic Parkinson Disease
National Center for Research Resources (NCRR)

Completed

Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease

Parkinson Disease

United States
Acorda Therapeutics

Completed

Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure (GGF2-1101-1)

Heart Failure

United States
Nicholls Spinal Injury Foundation
University College, London; Poznan University of Medical Sciences; Wroclaw Medical... and other collaborators

Recruiting

Autologous Bulbar Olfactory Ensheathing Cells and Nerve Grafts for Treatment of Patients With Spinal Cord Transection

Spinal Cord Injury at C5-Th10 Level With Complete Lesion | Spinal Cord Transection

Poland
University Hospital, Angers
Cémavie

Completed

Effects of Geriatric Inclusive Art Activity in Nursing Home Residents (GIA)

Geriatric Disorders

France
U.S. Army Medical Research and Development Command
United States Agency for International Development (USAID); IDRI

Completed

Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults

Malaria

United States
University Hospital, Montpellier

Completed

Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) (COVID-AKI)

COVID-19 | Acute Kidney Injury | Renal Replacement Therapy

France
Moscow Clinical Scientific Center

Unknown

Association Between Changes of GFAP After Surgery and Postoperative Delayed Cognitive Recovery

Postoperative Delirium | Postoperative Cognitive Dysfunction | Astrogliosis

Russian Federation
The Immunobiological Technology Institute (Bio-Manguinhos)...
Oswaldo Cruz Institute

Not yet recruiting

Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients

Leprosy

Brazil
Wakayama Medical University

Completed

A Prospective, Multi-center Trial for Reinforced Staple During Distal Pancreatectomy

Pancreatic Neoplasms

Japan
Instituto Mexicano del Seguro Social
Massachusetts General Hospital; Fundacion Rio Arronte

Active, not recruiting

Educational Intervention in the First 18 Months of Life to Prevent/Manage Obesity of Children After Gestational Diabetes

Overweight and Obesity | Gestational Diabetes

Mexico
Charite University, Berlin, Germany

Completed

Optimization of a Fast-track Concept for Knee Joint Replacement (KneeOptOut2)

Postoperative Complications | Postoperative Pain | Knee Arthropathy

Germany
Universitas Airlangga

Completed

MMP-9, TIMP-9 in Lung Imaging and Functional of COVID-19

COVID-19 | Extracellular Matrix Alteration | Pulmonary Infection

Indonesia
Access to Advanced Health Institute (AAHI)
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Completed

Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults

Pulmonary TB

United States
AvenCell Europe GmbH
PHARMALOG Institut für klinische Forschung GmbH

Recruiting

Dose-escalating Trial With UniCAR02-T Cells and CD123 Target Module (TM123) in Patients With Hematologic and Lymphatic Malignancies

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) | Acute Myeloid Leukemia (AML)

Germany
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Cannot Be Removed by Surgery

Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma

United States
Oswaldo Cruz Foundation
Financiadora de Estudos e Projetos

Completed

Study to Evaluate the Safety of the Vaccine Prepared sm14 Against Schistosomiasis

Schistosomiasis

Brazil
Fondazione Don Carlo Gnocchi Onlus
University of Florence

Recruiting

Sarcopenia and Nutritional Status in a Rehabilitation Setting

Sarcopenia

Italy
Eva de Miguel Balsa

Completed

Use of Urinary Cell-Cycle Arrest Biomarkers in Contrast-Associated Nephropathy After Coronary Angiography

Contrast-induced Nephropathy

Spain
International Vaccine Institute

Recruiting

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield®) Candidate Vaccine in Healthy Adults in Burkina Faso and Madagascar

Schistosomiasis

Burkina Faso, Madagascar
GREAT Network Italy

Completed

Biomarker Rule in/Out in Patients With Acute Diseases for Validation of AKI (BRAVA) Acute Kidney Injury (BRAVA)

Acute Kidney Injury

Korea, Republic of, Singapore, Australia, India, Thailand
Quratis Inc.

Unknown

Phase 1 Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Adolescent

Tuberculosis

Korea, Republic of
Quratis Inc.
IDRI

Unknown

Phase 2a Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Healthcare Workers

Tuberculosis

Korea, Republic of
IDRI
American Leprosy Missions

Completed

Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers

Leprosy

United States
Immune Design

Completed

A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma

Merkel Cell Carcinoma

United States
IDRI
South African Tuberculosis Vaccine Initiative; Aeras

Completed

Phase 1 ID93 + GLA-SE Vaccine Trial in BCG-Vaccinated Healthy Adult Volunteers

Pulmonary Tuberculosis

South Africa
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Safety, Tolerability, and Immunogenicity Study of Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy Adults

Schistosomiasis

United States
Medtronic - MITG

Completed

A Post-market Study of the Endo GIA™ Reinforced Reload With Tri-Staple™ Technology

Non-emergent, Abdominal or Thoracic Procedures

United Kingdom
Mayo Clinic
National Cancer Institute (NCI)

Completed

MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery

Stage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin Melanoma

United States
Sanofi

Completed

A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients

Food Allergy

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects

Tuberculosis

United States
Medtronic - MITG

Completed

ENDO GIA™ Stapler With ENDO GIA™ Reload With Tri-Staple™ Technology in a Pulmonary Resection

Lung Cancer

United States
Lexington Medical Inc.

Completed

Endostapler Sleeve Gastrectomy Study

Obesity

United States

Search clinical trials for: TIMP-GLIA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations